Ajanta Pharma Ltd Company Profile
What is the competitive landscape for AJANTA PHARMA LTD
AJANTA PHARMA LTD has seventy-three approved drugs.
There are five tentative approvals on AJANTA PHARMA LTD drugs.
Summary for Ajanta Pharma Ltd
| US Patents: | 0 |
| Tradenames: | 60 |
| Ingredients: | 59 |
| NDAs: | 73 |
Drugs and US Patents for Ajanta Pharma Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ajanta Pharma Ltd | OLANZAPINE | olanzapine | TABLET;ORAL | 206711-006 | Aug 30, 2016 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Ajanta Pharma Ltd | TOFACITINIB CITRATE | tofacitinib citrate | TABLET, EXTENDED RELEASE;ORAL | 219542-001 | Aug 19, 2025 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ajanta Pharma Ltd | TADALAFIL | tadalafil | TABLET;ORAL | 209654-001 | Mar 26, 2019 | AB1 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ajanta Pharma Ltd | FENOFIBRATE (MICRONIZED) | fenofibrate | CAPSULE;ORAL | 210705-002 | Sep 10, 2018 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ajanta Pharma Ltd | OXYBUTYNIN CHLORIDE | oxybutynin chloride | TABLET, EXTENDED RELEASE;ORAL | 211655-003 | Feb 28, 2019 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
